Eximia Research Network Acquires Tidewater Clinical Research
August 2, 2024
Eximia Research Network has acquired Tidewater Clinical Research, integrating the Virginia-based clinical trial site into its national network to expand geographic reach and therapeutic capabilities. The deal brings Tidewater's long-standing expertise in Women's Health and Ophthalmology and a ~97,000-patient database into Eximia's PE-backed platform (investor: VSS Capital Partners); Viking Mergers & Acquisitions advised the sellers.
- Buyers
- Eximia Research Network, VSS Capital Partners
- Targets
- Tidewater Clinical Research
- Sellers
- Kelley (Kelly) Fleming, April Rusch
- Industry
- Healthcare Services
- Location
- Virginia, United States
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.